검색어 : 통합검색[Coyne Richard]
총 266건 중 266건 출력
, 22/27 페이지
-
211
- Agricultural nematology in East and Southern Africa: problems, management strategies and stakeholder linkages
- Talwana, Herbert; Sibanda, Zibusiso; Wanjohi, Waceke; Kimenju, Wangai; Luambano‐ Nyoni, Nessie; Massawe, Cornel; Manzanilla‐ Ló pez, Rosa H; Davies, Keith G; Hunt, David J; Sikora, Richard A; Coyne, Danny L; Gowen, Simon R; Kerry, Brian R; Department of Crop Science, Faculty of Agriculture, Makerere University, Uganda; Goldengro Pvt Ltd, Harare, Zimbabwe; Agricultural Science and Technology, Kenyatta University, Nairobi, Kenya; Faculty of Agriculture, University of Nairobi, Nairobi, Kenya; Sugar Cane Research Institute, Kibaha, Tanzania; Tengeru Horticultural Research Institute, Arusha, Dar es Salaam, Tanzania; Department of AgroEcology, Rothamsted Research, Harpenden, Herts, UK; Department of AgroEcology, Rothamsted Research, Harpenden, Herts, UK; CABI Europe‐ UK, Egham, Surrey, UK; INRES‐ Phytomedizin, Bonn, Germany; IITA; (Pest management science, v.72, 2016, pp.226-245)
-
212
- Near Futures: Associative Archetypes
- Derix, Christian; Jagannath, Prarthana; ; (Architectural design : A.D, v.84, 2014, pp.130-135)
-
213
- Profound CD4 <sup>+</sup> /CCR5 <sup>+</sup> T cell expansion is induced by CD8 <sup>+</sup> lymphocyte depletion but does not account for accelerated SIV pathogenesis
- Okoye, Afam; Park, Haesun; Rohankhedkar, Mukta; Coyne-Johnson, Lia; Lum, Richard; Walker, Joshua M.; Planer, Shannon L.; Legasse, Alfred W.; Sylwester, Andrew W.; Piatak Jr., Michael; Lifson, Jeffrey D.; Sodora, Donald L.; Villinger, Francois; Axthelm, Michael K.; Schmitz, Joern E.; Picker, Louis J.; Vaccine and Gene Therapy Institute , Department of Pathology , Department of Molecular Microbiology and Immunology , and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; Vaccine and Gene Therapy Institute , Department of Pathology , Department of Molecular Microbiology and Immunology , and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; Vaccine and Gene Therapy Institute , Department of Pathology , Department of Molecular Microbiology and Immunology , and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; Vaccine and Gene Therapy Institute , Department of Pathology , Department of Molecular Microbiology and Immunology , and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; Vaccine and Gene Therapy Institute , Department of Pathology , Department of Molecular Microbiology and Immunology , and; (The Journal of experimental medicine, v.206, 2009, pp.1575-1588)
-
214
- Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.
- O'Sullivan Coyne, Geraldine Helen; Kummar, Shivaani; Do, Khanh Tu; Holbeck, Susan; Hollingshead, Melinda G.; Horneffer, Yvonne; Juwara, Lamin; Srivastava, Apurva K.; Rubinstein, Larry; Piekarz, Richard; Sharon, Elad; Streicher, Howard; Conley, Barbara A.; Antony, Ramya; Collins, Jerry M.; Chen, Alice; Doroshow, James H.; Early Clinical Trials Development Program,, Bethesda, MD; Phase I Clinical Research Program Stanford University School of Medicine, Stanford, CA; Dana-Farber Cancer Inst, Boston, MA; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, MD; Division of Cancer Treatment and Diagnosis, NCI, NIH, Frederick, MD; NCI, Bethesda, MD; NCI, Bethesda, MD; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD; Division of Cancer Treatment and Diagnosis, Bethesda, MD; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD; National Cancer Institute, Bethesda, MD; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Natl Cancer Inst, Rockville, MD; Leidos Biomedical Research, Inc., Frederick, MD; NCI/DCTD, Rockville, MD; Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, MD; Division of Cancer Treatment and Diagnosis, National Cancer; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.TPS2614-TPS2614)
-
215
- Phase 2 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with granulosa cell ovarian cancer.
- Shin, Sarah; O'Sullivan Coyne, Geraldine Helen; Zlott, Jennifer; Salkeni, Mohamad Adham; Takebe, Naoko; Ma, Ning; Rubinstein, Larry V.; Piekarz, Richard; Wilsker, Deborah; Ferry-Galow, Katherine V.; Miller, Brandon; Parchment, Ralph E.; Jiwani, Shahanawaz; Juwara, Lamin; Voth, Andrea; Doroshow, James H.; Chen, Alice P.; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; Biometric Research Program, Divis; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.5564-5564)
-
216
- 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models
- Loo, Yueh-Ming; Herbert, Andrew S; Kuehne, Ana I; McTamney, Patrick M; Roque, Richard; Moreau, Alicia M; Bakken, Russell; Stefan, Christopher P; Koehler, Jeffrey W; Delp, Korey L; Coyne, Susan R; Kane, Christopher D; Dye, John M; Cai, Yingyun; Esser, Mark T; AstraZeneca , Gaithersburg, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Disease , Fort Detrick, Maryland; AstraZeneca , Gaithersburg, Maryland; AstraZeneca , Gaithersburg, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland; United States Army M; (Open forum infectious diseases, v.9, 2022, pp.ofac492.981)
-
217
- A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction
- Takebe, Naoko; Beumer, Jan H.; Kummar, Shivaani; Kiesel, Brian F.; Dowlati, Afshin; O'Sullivan Coyne, Geraldine; Piekarz, Richard; Rubinstein, Lawrence; Fogli, Laura K.; Vaishampayan, Ulka; Goel, Sanjay; O'Bryant, Cindy L.; El‐ Rayes, Bassel F.; Chung, Vincent; Lenz, Heinz‐ Josef; Kim, Richard; Belani, Chandra P.; Tuscano, Joseph M.; Schelman, William; Moore, Nancy; Doroshow, James H.; Chen, Alice P.; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH, USA; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis,; (British journal of clinical pharmacology, v.85, 2019, pp.2499-2511)
-
218
- Phase I trial of 5-aza-4’-thio-2’-deoxycytidine (Aza-TdC) in patients with advanced solid tumors.
- Nguyen, James; O'Sullivan Coyne, Geraldine Helen; Takebe, Naoko; Naqash, Abdul Rafeh; Mukherjee, Jessica; Bruns, Ashley; Piekarz, Richard; Collins, Jerry M.; Anderson, Larry; Miller, Brandon; Parchment, Ralph E.; Rubinstein, Larry V; Kummar, Shivaani; Sharon, Elad; Streicher, Howard; Chen, Alice P.; Doroshow, James H.; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; ; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; ; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD; ; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD; ; Developmental Therapeutics Clinic/Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; ; National Cancer Institute, Bethesda, MD; ; Cancer Therapy Evaluation Program, N; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.3088-3088)
-
219
- Fragment-based development of small molecule inhibitors targeting<i>Mycobacterium tuberculosis</i>cholesterol metabolism
- Kavanagh Madeline E.; McLean Kirsty J.; Gilbert Sophie H.; Amadi Cecilia; Snee Matthew; Tunnicliffe Richard B.; Arora Kriti; Boshoff Helena I.; Fanourakis Alexander; Rebello-Lopez Maria Jose; Ortega-Muro Fatima; Levy Colin W.; Munro Andrew W.; Leys David; Abell Chris; Coyne Anthony G.; ; (, v., 2024, )
-
220
- RNA methylation controls stress granule formation and function during erythropoiesis
- Gunage Rajesh; Lin Shuibin; Wiley David; Choudhuri Avik; Smith Mackenzie; Han Tianxiao; Shah Arish; Coyne Steven; Koczirka Katherine; Chen Kenny Zhi Ming; Yu Chunjie; Drake Kyle; Yang Xin; Yang Song; Zhou Yi; Bauer Daniel; Qian Zhijian; Calo Eliezer; Gregory Richard I.; Zon Leonard I.; ; (, v., 2024, )
QUICK MENU
